Area of research
Surgery · Physiology
Research interest
Research focused on In vitro and Apoptosis, with related work in Insulin resistance, Cancer research, Furoxan. Notable publications include 'Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease', 'MRTF-A-NF-κB/p65 axis-mediated PDL1 transcription and expression contributes to immune evasion of non-small-cell lung cancer via TGF-β', and 'Synthesis and biological evaluation of nitric oxide-releasing hybrids from gemcitabine and phenylsulfonyl furoxans as anti-tumor agents'.
Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease
MRTF-A-NF-κB/p65 axis-mediated PDL1 transcription and expression contributes to immune evasion of non-small-cell lung cancer via TGF-β
Cardiovascular Outcomes in the Patients With Primary Central Nervous System Lymphoma: A Multi-Registry Based Cohort Study of 4,038 Cases
A multiscale model to study the enhancement in the compressive strength of multi-walled CNT sheet overwrapped carbon fiber composites
Synthesis and biological evaluation of nitric oxide-releasing hybrids from gemcitabine and phenylsulfonyl furoxans as anti-tumor agents
Benzylidene 2-Aminoimidazolones Derivatives: Synthesis and <i>in Vitro</i> Evaluation of Anti-tumor Carcinoma Activity
Synthesis and in vitro biological evaluation of novel 2-aminoimidazolone derivatives as anti-tumor agents